Science Explorer Back to mapMap
Discussion
Company · Lodi · Italy

IBSA Farmaceutici (Italy)

ibsa.it/home.htmlROR OpenAlex
Research works
58
▲ 49% vs 2018-21
Citations
848
14.6 per fractional work
Top-10% rate
20.9%
all institutions 10.0%
Open access
60%
world 40%
International
24%
world 18%
IBSA Farmaceutici (Italy)

Not ranked overall: IBSA Farmaceutici (Italy) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does IBSA Farmaceutici (Italy) work in?

In 2022-now, 67% of research at IBSA Farmaceutici (Italy) is in Health Sciences, 26% in Life Sciences. Its largest fields are Medicine (65%), Biochemistry, Genetics and Molecular Biology (12%), Agricultural and Biological Sciences (8%). It does 2.2× the world's share of Health Sciences.

Health Sciences: 14 fractional works · 67.2% of its workMedicine: 14 fractional works · 64.6% of its workDermatology: 7 fractional works · 35.3% of its workUrology: 1 fractional works · 4.9% of its workPhysiology: 1 fractional works · 4.7% of its workNeurology: 1 fractional works · 2.8% of its workPsychiatry and Mental health: 1 fractional works · 2.5% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 2.5% of its workSurgery: 1 fractional works · 2.4% of its workRehabilitation: 0 fractional works · 1.3% of its workImmunology and Allergy: 0 fractional works · 1.1% of its workRheumatology: 0 fractional works · 1.1% of its workHematology: 0 fractional works · 0.8% of its workPathology and Forensic Medicine: 0 fractional works · 0.8% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.7% of its workEpidemiology: 0 fractional works · 0.6% of its workOncology: 0 fractional works · 0.6% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.4% of its workComplementary and alternative medicine: 0 fractional works · 0.4% of its workOphthalmology: 0 fractional works · 0.4% of its workPharmacology: 0 fractional works · 0.3% of its workPulmonary and Respiratory Medicine: 0 fractional works · 0.3% of its workGeriatrics and Gerontology: 0 fractional works · 0.2% of its workOtorhinolaryngology: 0 fractional works · 0.2% of its workHealth Professions: 0 fractional works · 1.9% of its workPharmacy: 0 fractional works · 0.8% of its workSpeech and Hearing: 0 fractional works · 0.8% of its workGeneral Health Professions: 0 fractional works · 0.3% of its workNursing: 0 fractional works · 0.7% of its workNutrition and Dietetics: 0 fractional works · 0.7% of its workLife Sciences: 5 fractional works · 25.7% of its workBiochemistry, Genetics and Molecular Biology: 3 fractional works · 12.2% of its workMolecular Biology: 1 fractional works · 4.1% of its workCell Biology: 1 fractional works · 3.2% of its workGenetics: 0 fractional works · 1.6% of its workCancer Research: 0 fractional works · 0.9% of its workMolecular Medicine: 0 fractional works · 0.8% of its workBiochemistry: 0 fractional works · 0.7% of its workBiotechnology: 0 fractional works · 0.5% of its workClinical Biochemistry: 0 fractional works · 0.4% of its workAgricultural and Biological Sciences: 2 fractional works · 7.6% of its workInsect Science: 1 fractional works · 3.2% of its workFood Science: 1 fractional works · 3.0% of its workEcology, Evolution, Behavior and Systematics: 0 fractional works · 0.6% of its workAquatic Science: 0 fractional works · 0.4% of its workPlant Science: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.0% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 2.6% of its workPharmaceutical Science: 0 fractional works · 2.0% of its workPharmacology: 0 fractional works · 0.6% of its workNeuroscience: 0 fractional works · 2.1% of its workCellular and Molecular Neuroscience: 0 fractional works · 1.2% of its workBehavioral Neuroscience: 0 fractional works · 0.5% of its workSensory Systems: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workImmunology and Microbiology: 0 fractional works · 1.2% of its workImmunology: 0 fractional works · 1.2% of its workPhysical Sciences: 1 fractional works · 4.4% of its workMaterials Science: 0 fractional works · 1.9% of its workBiomaterials: 0 fractional works · 1.1% of its workMaterials Chemistry: 0 fractional works · 0.5% of its workSurfaces, Coatings and Films: 0 fractional works · 0.3% of its workChemistry: 0 fractional works · 1.5% of its workOrganic Chemistry: 0 fractional works · 0.9% of its workPhysical and Theoretical Chemistry: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.0% of its workEnvironmental Science: 0 fractional works · 0.7% of its workEnvironmental Chemistry: 0 fractional works · 0.4% of its workEcology: 0 fractional works · 0.3% of its workEngineering: 0 fractional works · 0.4% of its workBiomedical Engineering: 0 fractional works · 0.4% of its workSocial Sciences: 1 fractional works · 2.6% of its workPsychology: 0 fractional works · 1.6% of its workClinical Psychology: 0 fractional works · 1.6% of its workSocial Sciences: 0 fractional works · 0.7% of its workEducation: 0 fractional works · 0.4% of its workHealth: 0 fractional works · 0.3% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.4% of its workEconomics and Econometrics: 0 fractional works · 0.4% of its workALL ITS WORKIBSA Farmaceutici(Italy)21fractional works, 2022-now
Life Sciences26%Physical Sciences4%Health Sciences67%Social Sciences3%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 15 fields, with their numbers
    1. Medicine1464.6%
    2. Health Professions01.9%
    3. Nursing00.7%
    1. Biochemistry, Genetics and Molecular Biology312.2%
    2. Agricultural and Biological Sciences27.6%
    3. Pharmacology, Toxicology and Pharmaceutics12.6%
    4. Neuroscience02.1%
    5. Immunology and Microbiology01.2%
    1. Materials Science01.9%
    2. Chemistry01.5%
    3. Environmental Science00.7%
    4. Engineering00.4%
    1. Psychology01.6%
    2. Social Sciences00.7%
    3. Economics, Econometrics and Finance00.4%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 1.60× its world share, 2 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.28× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 1.25× its world share, 0 worksImmunology and Micro…Neuroscience: 1.29× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 7.35× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.93× its world share, 0 worksChemistryEngineering: 0.03× its world share, 0 worksEngineeringEnvironmental Science: 0.14× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.53× its world share, 0 worksMaterials ScienceHealth Professions: 0.71× its world share, 0 worksHealth ProfessionsMedicine: 3.36× its world share, 14 worksMedicineNursing: 1.45× its world share, 0 worksNursingEconomics, Econometrics and Finance: 0.19× its world share, 0 worksEconomics, Econometr…Psychology: 0.52× its world share, 0 worksPsychologySocial Sciences: 0.05× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 7.3×. Every wedge is a field page.

All 15 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics7.35×0 works
  2. Medicine3.36×14 works
  3. Biochemistry, Genetics and Molecular Biology2.28×2 works
  4. Agricultural and Biological Sciences1.60×2 works
  5. Nursing1.45×0 works
  6. Neuroscience1.29×0 works
  7. Immunology and Microbiology1.25×0 works
  8. Chemistry0.93×0 works
  9. Health Professions0.71×0 works
  10. Materials Science0.53×0 works
  11. Psychology0.52×0 works
  12. Economics, Econometrics and Finance0.19×0 works
  13. Environmental Science0.14×0 works
  14. Social Sciences0.05×0 works
  15. Engineering0.03×0 works

Who are the top researchers at IBSA Farmaceutici (Italy)?

Ranked on the quality score, Franco Grimolizzi, Gilberto Bellia and Andrea Maria Giori lead among researchers whose main affiliation is IBSA Farmaceutici (Italy).

  1. 1 Franco Grimolizzi Italy · #1,192,115 worldwide 747 citations · 39 works
  2. 2 Gilberto Bellia Italy · #1,862,147 worldwide 785 citations · 56 works
  3. 3 Andrea Maria Giori Italy · #2,962,549 worldwide 746 citations · 39 works
  4. 4 Beatriz Molina Italy · #3,364,109 worldwide 204 citations · 25 works
  5. 5 G. Tortolani Italy · #4,354,393 worldwide 79 citations · 18 works
All ranked researchers at IBSA Farmaceutici (Italy)

What are the most cited papers from IBSA Farmaceutici (Italy)?

The most cited paper from IBSA Farmaceutici (Italy) is "Targeting senescence induced by age or chemotherapy with a polyphenol-rich natural extract improves longevity and healthspan in mice" (Sara Zumerle et al., 2024), with 107 citations. Next come "CXCR1/2 Inhibition Blocks and Reverses Type 1 Diabetes in Mice" (92) and "CXCR1 and CXCR2 Inhibition by Ladarixin Improves Neutrophil-Dependent Airway Inflammation in Mice" (68).

Most cited papers
#PaperReleasedCitations
1 Targeting senescence induced by age or chemotherapy with a polyphenol-rich natural extract improves longevity and healthspan in mice Sara Zumerle et al. · Nature Aging Open access Jul 2024 107
2 CXCR1/2 Inhibition Blocks and Reverses Type 1 Diabetes in Mice Antonio Citro, Andrea Valle, Elisa Cantarelli et al. · Diabetes 14 Oct 2014 92
3 CXCR1 and CXCR2 Inhibition by Ladarixin Improves Neutrophil-Dependent Airway Inflammation in Mice Matheus Silvério Mattos, Maximiliano Ruben Ferrero, Lucas Rocha Kraemer et al. · Frontiers in Immunology Open access 2 Oct 2020 68
4 CXCR1/2 Antagonism Is Protective during Influenza and Post-Influenza Pneumococcal Infection Luciana P. Tavares, Cristiana Couto Garcia, Marina Machado et al. · Frontiers in Immunology Open access 13 Dec 2017 68
5 Cysteine Prevents the Reduction in Keratin Synthesis Induced by Iron Deficiency in Human Keratinocytes Maria Concetta Miniaci, Carlo Irace, Antonella Capuozzo et al. · Journal of Cellular Biochemistry 25 Jul 2015 60
All 60 most cited papers, with filters and sorting

Which keywords describe research at IBSA Farmaceutici (Italy)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Complications, Wound Healing, Cosmetic Surgery, Dermal Fillers, Hyaluronic Acid, Hypertrophic Scarring, Keloids and Inflammation.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 16 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 16 words, with their numbers
  1. Complications3▲ 33×3 topics
  2. Wound Healing3▲ 60×4 topics
  3. Cosmetic Surgery3▲ 364×2 topics
  4. Dermal Fillers3▲ 603×1 topic
  5. Hyaluronic Acid3▲ 603×1 topic
  6. Hypertrophic Scarring3▲ 465×1 topic
  7. Inflammation3▲ 6.0×22 topics
  8. Keloids3▲ 465×1 topic
  9. Oxidative Stress2▲ 4.9×12 topics
  10. Matrix Metalloproteinases1▲ 43×3 topics
  11. Quality of Life1▲ 4.3×7 topics
  12. Epidemiology1▲ 1.49×8 topics
  13. Treatment1▲ 4.6×3 topics
  14. Antioxidant1▲ 7.4×8 topics
  15. Regeneration1▲ 27×3 topics
  16. Stem Cells1▲ 18×4 topics

Which research topics does IBSA Farmaceutici (Italy) publish most on?

By volume in 2022-now: Facial Rejuvenation and Surgery Techniques, Dermatologic Treatments and Research, Skin Protection and Aging and Hair Growth and Disorders.

Facial Rejuvenation and …3Facial Rejuvenation and Surgery Techniques: 3 fractional worksDermatologic Treatments …3Dermatologic Treatments and Research: 3 fractional worksSkin Protection and Aging1Skin Protection and Aging: 1 fractional worksHair Growth and Disorders1Hair Growth and Disorders: 1 fractional worksProteoglycans and glycos…0Proteoglycans and glycosaminoglycans research: 0 fractional worksBotulinum Toxin and Related Neurological Disorders: 0 fractional worksDermatology and Skin Diseases: 0 fractional worksAcne and Rosacea Treatments and Effects: 0 fractional worksAdvanced Drug Delivery Systems: 0 fractional worksPeriodontal Regeneration and Treatments: 0 fractional works
DermatologyUrologyCell BiologyNeurology1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Facial Rejuvenation and Surgery Techniques Dermatology 3 works
  2. 2 Dermatologic Treatments and Research Dermatology 3 works
  3. 3 Skin Protection and Aging Dermatology 1 works
  4. 4 Hair Growth and Disorders Urology 1 works
  5. 5 Proteoglycans and glycosaminoglycans research Cell Biology 0 works
  6. 6 Botulinum Toxin and Related Neurological Disorders Neurology 0 works
  7. 7 Dermatology and Skin Diseases Dermatology 0 works
  8. 8 Acne and Rosacea Treatments and Effects Dermatology 0 works
  9. 9 Advanced Drug Delivery Systems Pharmaceutical Science 0 works
  10. 10 Periodontal Regeneration and Treatments Urology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available59.6%not open40.4%

World: 40% of research is openly available.

with international co-authors23.8%domestic only76.2%

World: 18% is written across borders.

How has IBSA Farmaceutici (Italy)'s research output changed?

Output in 2022-2025 was 49% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is IBSA Farmaceutici (Italy) as a percentage of every work published that year, 0.00012% in 2024.

still counting0.00025%0.00050%0.00075%IBSA Farmaceutici (Italy)0.000052% in 202519801990200020102020

Fractional works of IBSA Farmaceutici (Italy) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Lodi

All research institutions in Lodi

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about IBSA Farmaceutici (Italy). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.